DAPSONE HYPERSENSITIVITY SYNDROME - A CASE REPORT
Open Access
- 1 September 2014
- journal article
- case report
- Published by Scientific Scholar in Journal of Health and Allied Sciences NU
- Vol. 04 (03) , 124-126
Abstract
Dapsone is widely used for a variety of infectious, immune and hypersensitivity disorders. However, the use of dapsone may be associated with a plethora of adverse effects.We are reporting a 6 year old who was treated with dapsone for one month. He presented to us with low grade fever and skin lesions all over body with normal systemic examination. He was evaluated and was diagnosed as having Dapsone Hypersensitivity Syndrome (DHS) and treated with steroids.The incidence of DHS ranges from 0.5% to3%. DHS can present as early as 7–10 days after administration of the drug uptil 6 months into. therapy DHS must be promptly identified, asUntreated the disorder could be fatal. This syndrome is best approached with the immediate discontinuation of the offending drug and prompt administration of oral or intravenous glucocorticoids.Since dapsone is used for various indications, the salient features about the syndrome and its management should be familiarized.Keywords
This publication has 4 references indexed in Scilit:
- Clinical evaluation and management of drug hypersensitivityImmunology and Allergy Clinics of North America, 2004
- Reactive Metabolites and Adverse Drug Reactions: Clinical ConsiderationsClinical Reviews in Allergy & Immunology, 2003
- Dapsone and sulfones in dermatology: Overview and updateJournal of the American Academy of Dermatology, 2001
- Dapsone hypersensitivity syndromeJournal of the American Academy of Dermatology, 1996